The Efficacy & Safety of rTMS for Upper-limb Motor Function Recovery in Subcortical and Brainstem Stroke
Launched by SEOUL NATIONAL UNIVERSITY BUNDANG HOSPITAL · Sep 7, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called repetitive transcranial magnetic stimulation (rTMS) to see if it can help people recover movement in their arms after having a stroke that affects certain areas deep in the brain. The treatment uses a special device called 'ALTMS-A' to send gentle magnetic pulses to the brain, which may help improve arm function. The study compares this treatment to a fake (sham) version to find out if it really works and is safe.
People who might join the study are adults between 19 and 80 years old who have had a specific type of stroke within the last three months, affecting parts of the brain that control movement, and who still have some ability to move their arm. Participants need to be mentally able to understand and take part in the study and agree to it in writing. Those with other types of brain injury, previous strokes, or medical conditions that could affect safety or results won’t be eligible. If you join, you’ll receive regular treatment sessions and physical therapy, and the study team will carefully check your progress and any side effects. This study is currently looking for volunteers who fit these criteria.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 19-80 years old
- • Radiologically confirmed ischemic stroke with subcortical and brainstem lesions within 90 days
- • Fugl-Meyer assessment scale (upper extremity) \> 15
- • Mini-mental status exam (the Korean version) \> 14 with appropriate cognitive function
- • Written informed consent
- Exclusion Criteria:
- • Fugl-Meyer assessment scale (wrist) \< 1 or Fugl-Meyer assessment scale (hand) \< 1
- • Hemorrhagic stroke or traumatic brain injury
- • Cerebellar stroke
- • Previous history of stroke
- • Traumatic brain injury
- • Previous history of brain surgery
- • Need for intensive care due to complications associated with stroke (e.g. pneumonia, infection, hemodynamic instability)
- • History of psychological or neurological diseases
- • History of pain or muscular weakness of upper limbs which may interfere with rehabilitation
- • History of seizure or epilepsy
- • Aphasia
- • Skin lesions in the stimulation site of scalp
- • Intracranial metal implant
- • Inability to receive regular physical or occupational therapy
- • Disagreement to use contraception in women of childbearing age
About Seoul National University Bundang Hospital
Seoul National University Bundang Hospital is a leading academic medical center located in South Korea, renowned for its commitment to innovative research and excellence in patient care. As a sponsor of clinical trials, the hospital leverages its extensive expertise in various medical fields, employing cutting-edge technologies and methodologies to advance healthcare solutions. With a multidisciplinary team of skilled researchers and clinicians, the hospital aims to enhance clinical outcomes through rigorous investigation and collaboration, contributing significantly to the global medical community and improving patient lives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seongnam Si, Korea, Gyeonggi Do, Korea, Republic Of
Daejeon, , Korea, Republic Of
Seongnam Si, , Korea, Republic Of
Patients applied
Trial Officials
Nam-Jong Paik, MD, PhD
Principal Investigator
Department of Rehabilitation Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials